Vice President of Clinical Operations

ONL Therapeutics

Lindsay Puscas, MS, COA, CCRP, serves as Vice President of Clinical Operations at ONL Therapeutics. With more than 15 years of clinical research experience and a specialized background in ophthalmic clinical trials, she has led ONL’s clinical team to complete four trials and advance the company’s lead compound, xelafaslatide (formerly ONL1204), into a global Phase 2 program. Before joining ONL, Lindsay served as Clinical Research Project Manager for the Kellogg Eye Center at the University of Michigan. Over ten years there, she oversaw a portfolio of more than 200 clinical studies spanning Phase 0 through post-market approval, with a focus on pediatric gene therapy trials for inherited retinal dystrophies.

A Certified Clinical Research Professional and Certified Ophthalmic Assistant, Lindsay earned her B.S. in Nutritional Sciences from Michigan State University and her M.S. in Nutrition and Food Science from Wayne State University.

A true Michigander, Lindsay plays ice hockey and is mom to two toddlers who already love vacationing up North.